6-31588608-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_205839.3(LST1):c.226G>T(p.Asp76Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,122 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_205839.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LST1 | NM_205839.3 | c.226G>T | p.Asp76Tyr | missense_variant | 5/5 | ENST00000438075.7 | NP_995311.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LST1 | ENST00000438075.7 | c.226G>T | p.Asp76Tyr | missense_variant | 5/5 | 1 | NM_205839.3 | ENSP00000391929 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000527 AC: 13AN: 246796Hom.: 1 AF XY: 0.0000298 AC XY: 4AN XY: 134436
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1460790Hom.: 1 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 726702
GnomAD4 genome AF: 0.000236 AC: 36AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The c.247G>T (p.D83Y) alteration is located in exon 4 (coding exon 4) of the LST1 gene. This alteration results from a G to T substitution at nucleotide position 247, causing the aspartic acid (D) at amino acid position 83 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at